Xu Luo, PhD

Membership Biographical Information

luo pict
Xu Luo, PhD


Primary Interest

Aberrant suppression of apoptosis contributes to  oncogenic transformation and resistance to therapeutic treatments. We are  interested in the regulation of mitochondria-dependent apoptotic pathway by the  Bcl-2 family proteins. Our goal is to uncover the molecular mechanisms of  apoptosis and provide insights into the design of therapeutic drugs against  cancer.


Link to Publications

Nebraska Research

Link to Profile

Eppley Institute for Research in Cancer and Allied Diseases

Link to Faculty Bio